Alginate type and RGD density control myoblast phenotype

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Cell Biology

Background:

• Alginates are widely used in cell encapsulation and tissue engineering.
• Current alginate materials lack specific interactions with mammalian cells, limiting their application.
• Covalent modification of alginates is needed to enhance cell adhesion and function.

Purpose of the Study:

• To covalently modify alginates with RGD-containing ligands to promote mammalian cell adhesion.
• To investigate the influence of alginate monomeric ratio and RGD ligand density on cell behavior.
• To control C2C12 skeletal myoblast proliferation and differentiation on modified alginate hydrogels.

Main Methods:

• Covalent modification of alginates with RGD ligands using carbodiimide chemistry.
• Controlled variation of RGD surface density (1-100 fmol/cm(2)) on alginates with different monomeric ratios.
• Assessment of C2C12 myoblast adhesion, proliferation, and differentiation on modified alginate hydrogels.

Main Results:

• Myoblast adhesion was specific to the RGD ligand and could be competed by soluble RGD.
• Alginate monomeric ratio and RGD density significantly regulated myoblast proliferation.
• Specific combinations of alginate type and RGD density were identified as crucial for efficient myoblast differentiation.

Conclusions:

• RGD-modified alginates enable specific cell adhesion and functional control of adherent cells.
• Tailoring alginate composition and RGD ligand density provides a strategy for optimizing cell behavior in tissue engineering.
• This approach offers a promising platform for developing advanced biomaterials for regenerative medicine.